The debate about treating "low T" in older men is heating up

May 2014

Please see the March 2015 FDA notice concerning the possible increased risk of heart attack/stroke associated with testosterone use.

The debate about treating "low T" in older men is heating up...due to controversy over testosterone's cardiovascular risk.

A recent JAMA study has FDA investigating a possible link between testosterone therapy and heart attacks and strokes.

Critics say the JAMA study is flawed.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Geriatrics promoting appropriate use of high-risk meds in the elderly
Testosterone The debate about treating "low T" in older men is heating up
Alzheimer's Disease switching patients' meds when Namenda (memantine) tabs are discontinued this August
Cardiology more focus on optimizing medication use after hospital discharge for a heart attack
Respiratory & Allergy when and how to use spacers with metered-dose inhalers (MDIs)
Neurology & Pain more interest in "abuse-deterrent" opioid formulations
Dermatology Luzu (LOO-zoo, luliconazole) will raise questions about how to treat common tinea infections
Diabetes Which meds can actually increase the risk of developing diabetes
Antithrombotics more antithrombotic choices for atrial fib
Women's Health treatment of polycystic ovary syndrome (PCOS)
Supplements Patients are asking if multivitamins are beneficial
Cardiology pharmacists help improve care and quality measures for patients hospitalized for an acute MI
OTC Products People may be confused by the new Mucinex Allergy product